Ocrelizumab is granted EU licence for PPMS and RRMS

Discuss Ocrelizumab, a monoclonal antibody treatment for MS.

Ocrelizumab is granted EU licence for PPMS and RRMS

Postby MSUK » Fri Jan 12, 2018 5:51 am

Ocrelizumab is granted EU licence for primary progressive and relapsing remitting MS

The European Commission (EC) has granted a licence for the use of ocrelizumab, also known as Ocrevus, in people with primary progressive multiple sclerosis (PPMS) and relapsing remitting multiple sclerosis (RRMS)…Read more - http://www.ms-uk.org/ocrelizumab-granted-eu-licence-primary-progressive-and-relapsing-remitting-ms

Image
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Return to Ocrevus (Ocrelizumab)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service


cron